- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00499135 | Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Oct 10, 2017 | clinicaltrials |
| NCT01263145 | MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Aug 25, 2017 | clinicaltrials |
| NCT00541359 | Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 54 | City of Hope Medical CenterOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT00471562 | Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 18 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00408499 | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | University of California, DavisOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | completed | Phase 1 | 74 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT01957995 | Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | University of Southern CaliforniaOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00731276 | Irinotecan in Treating Asian Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Centre, SingaporeOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT00878904 | Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors | completed | Phase 1 | 40 | University of California, San FranciscoOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT00662636 | Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 27 | Mayo ClinicOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00311597 | Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 48 | Wake Forest University Health SciencesOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00004927 | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | R-PharmINDUSTRY | 1 | Jan 30, 2017 | clinicaltrials |
| NCT00949949 | Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy | completed | Phase 1 | 38 | Mayo ClinicOTHER | 1 | Jan 12, 2017 | clinicaltrials |
| NCT00003899 | Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00019565 | PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy | completed | Phase 1 | 53 | National Institutes of Health Clinical Center (CC)NIH | 1 | Sep 26, 2016 | clinicaltrials |
| NCT00416637 | Bevacizumab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Herbert Hurwitz, MDOTHER | 0 | Jul 7, 2016 | clinicaltrials |
| NCT00026195 | Irinotecan in Treating Aging Patients With Solid Tumors | completed | Phase 1 | 140 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00002994 | Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors | completed | Phase 1 | 355 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00036946 | VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | — | Regeneron PharmaceuticalsINDUSTRY | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00045266 | VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | — | Regeneron PharmaceuticalsINDUSTRY | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00933777 | SORAVE - Sorafenib and Everolimus in Solid Tumors(SORAVE) | completed | Phase 1 | 36 | University of CologneOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01418677 | An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function | completed | Phase 1 | 19 | Eisai Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT01276496 | Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2016 | clinicaltrials |
| NCT00303732 | Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors(PTK/RAD) | completed | Phase 1 | 37 | Daniel George, MDOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01450384 | Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Virginia Commonwealth UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00714181 | Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 38 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT01061749 | Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00008125 | Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | University of PittsburghOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT00014378 | Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00547547 | High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 22 | City of Hope Medical CenterOTHER | 1 | Nov 6, 2015 | clinicaltrials |
| NCT01625156 | Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery | completed | Phase 1 | 11 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00276536 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma(IFNa) | completed | Phase 1 | 35 | The Cleveland ClinicOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00884676 | Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 36 | Jaime MerchanOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00607724 | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Genentech, Inc.INDUSTRY | 0 | Oct 8, 2015 | clinicaltrials |
| NCT01039155 | Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01548482 | Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01560325 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 21 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Sep 16, 2015 | clinicaltrials |
| NCT00121277 | Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 28 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00126620 | Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 17 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00608361 | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT01154426 | ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT00005078 | Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors | completed | Phase 1 | 44 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00005839 | Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00550901 | Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT00423865 | Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01281150 | Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | May 25, 2015 | clinicaltrials |
| NCT00535119 | Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer | completed | Phase 1 | 107 | National Cancer Institute (NCI)NIH | 1 | May 22, 2015 | clinicaltrials |
| NCT00521144 | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 10, 2017source: clinicaltrials